Newsquawk Logo

PRE-MARKET INDIAN STOCKS NEWS: ABB India (ABB IS) Q4 (INR) consolidated profit declined 18.1% Y/Y to 4.3bln (prev. 5.3bln), while revenue increased 5.7% Y/Y to 35.6bln (prev. 33.6bln)

Importance
Level 1

ABB India (ABB IS) - Co. Q4 (INR) consolidated profit declined 18.1% Y/Y to 4.3bln (prev. 5.3bln), while revenue increased 5.7% Y/Y to 35.6bln (prev. 33.6bln). (Moneycontrol)

CIE Automotive India (CIEINDIA IS) - Co. Q4 (INR) consolidated profit advanced 10.4% Y/Y to 2.0bln, with revenue climbing 13.4% Y/Y to 23.9bln. (Moneycontrol)

Federal Bank (FEDERALBNK IS) - Co. is set to receive INR 6.86bln tax refund after resolving a long-pending tax dispute, which is expected to aid profitability in the coming quarter. (ET)

Hindustan Unilever (HUVR IS) - Co. plans to invest up to INR 20.0bln over the next two years to expand production capacity in premium Beauty & Wellbeing and Home Care liquids segments. (ET)

ICICI Prudential Life Insurance (IPRU IS) - Co. received an adverse appellate ruling affirming an INR 9.84bln tax demand and said it will pursue a further appeal. (ET)

Novartis India (HCBA IS) - Co. promoter Novartis AG (NOVN SW) agreed to divest its 70.68% holding in Novartis India to WaveRise Investments, ChrysCapital Fund X and Two Infinity Partners. (Moneycontrol)

Zydus Lifesciences (CDH IS) - Co. introduced its first domestically developed biosimilar aimed at treating visual impairment. (ET)

#SWITZERLAND#INDIA#INR#ASIA#PRUDENTIAL PLC#UNILEVER PLC#NOVARTIS AG#HINDUSTAN UNILEVER LTD#HUVR.IS#FEDERAL CORP#ABB INDIA LTD#ABB.IS#CADILA HEALTHCARE LTD#CDH.IS#EQUITIES#ASIAN SESSION#HIGHLIGHTED#RESEARCH SHEET#PERSONAL CARE PRODUCTS#PHARMACEUTICALS#LIFE & HEALTH INSURANCE#PERSONAL CARE PRODUCTS (GROUP)#PHARMACEUTICALS (GROUP)#INSURANCE#HOUSEHOLD & PERSONAL PRODUCTS#PHARMACEUTICALS, BIOTECHNOLOGY & LIFE SCIENCES#INSURANCE (GROUP)#SWISS MARKET INDEX#NOVN#ASIAN EQUITIES
Published: Updated: